Cyclic adenosine monophosphate-dependent cell type-specific modulation of mitogenic signaling by retinoids in normal

Hussein A N Al-Wadei1, Hildegard M Schuller

  • 1Experimental Oncology Laboratory, Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA.

Abstract

Insights

Retinoids 9-cis-retinoic acid (9-Cis-RA) and 13-cis-retinoic acid (13-Cis-RA) activate cAMP and PKA. This may inhibit small cell lung cancer but promote adenocarcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Lung cancer is a leading cause of cancer death globally.
  • Fruit and vegetable consumption may reduce lung cancer risk.
  • Previous trials with beta-carotene and retinoids showed increased mortality.

Purpose of the Study:

  • Investigate the effects of 9-cis-retinoic acid (9-Cis-RA) and 13-cis-retinoic acid (13-Cis-RA) on lung cancer cells.
  • Examine the role of cAMP, PKA, and ERK1/2 pathways in retinoid-induced effects.

Main Methods:

  • Utilized MTT assays for cell proliferation.
  • Employed cAMP immunoassays and PKA activation assays.
  • Analyzed ERK1/2 phosphorylation using Western blots in various human lung cell lines.

Main Results:

  • Both 9-Cis-RA and 13-Cis-RA increased intracellular cAMP and PKA activation in all tested cell lines.
  • In BEAS-2B and NCI-H69 cells, cAMP/PKA stimulation reduced ERK1/2 phosphorylation and inhibited cell proliferation.
  • Conversely, in HPL1D and NCI-H322 cells, cAMP/PKA stimulation increased ERK1/2 phosphorylation and cell proliferation.

Conclusions:

  • Identified a novel mechanism: 9-Cis-RA and 13-Cis-RA activate PKA via increased cAMP.
  • cAMP/PKA stimulation may inhibit small cell lung carcinoma and large airway epithelial tumors.
  • This pathway may selectively promote lung adenocarcinoma development from small airway epithelial cells.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...